Head-and-neck stages I and II extranodal non-Hodgkin’s lymphomas: real classification and selection for treatment modality

Doll, 1999, Extranodal lymphomas, Semin Oncol, 26, 249 Miller, 1998, Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin’s lymphoma, N Engl J Med, 339, 21, 10.1056/NEJM199807023390104 Isaacson, 1987, Malignant lymphoma of mucosa-associated lymphoid tissue, Histopathology, 11, 445, 10.1111/j.1365-2559.1987.tb02654.x Isaacson, 1984, Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue, Cancer, 53, 2515, 10.1002/1097-0142(19840601)53:11<2515::AID-CNCR2820531125>3.0.CO;2-C Pelstring, 1991, Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues, Am J Clin Pathol, 96, 738, 10.1093/ajcp/96.6.738 Harris, 1994, A revised European–American classification of lymphoid neoplasms, Blood, 84, 1361, 10.1182/blood.V84.5.1361.1361 Tsutsui, 1991, A radiotherapeutic experience for localized extranodal non-Hodgkin’s lymphoma, Radiother Oncol, 21, 83, 10.1016/0167-8140(91)90079-V Yuen, 1999, Lymphomas of the head and neck, Semin Oncol, 26, 338 Sasai, 1996, Non-Hodgkin’s lymphoma of the thyroid. A clinical study of twenty-two cases, Acta Oncol, 35, 457, 10.3109/02841869609109922 Sasai, 1997, Primary testicular non-Hodgkin’s lymphoma, Am J Clin Oncol, 20, 59, 10.1097/00000421-199702000-00013 Perez, 1992, Overview, 1 Miller, 1990, Unfavorable histologies of non-Hodgkin’s lymphoma treated with ProMACE-CytaBOM, J Clin Oncol, 8, 1951, 10.1200/JCO.1990.8.12.1951 Jaffe ES. Histopathology and immunopathology. In: Magrath I, editor. The non-Hodgkin’s lymphoma. 3rd ed. London: Arnold; Arnold; 1997. p. 79–131. Kamath, 1999, The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in Stage I and II non-Hodgkin’s lymphoma, Int J Radiat Oncol Biol Phys, 44, 563, 10.1016/S0360-3016(99)00051-6 Esik, 1996, A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin’s lymphomas, Radiother Oncol, 38, 13, 10.1016/0167-8140(95)01658-9 Reddy, 1988, Primary orbital lymphomas, Int J Radiat Oncol Biol Phys, 15, 1239, 10.1016/0360-3016(88)90210-6 Letschert, 1991, Results of radiotherapy in patients with stage I orbital non-Hodgkin’s lymphoma, Radiother Oncol, 22, 36, 10.1016/0167-8140(91)90067-Q Cheng, 1993, Characteristics clinicopathologic features of Epstein–Barr virus-associated peripheral T-cell lymphoma, Cancer, 72, 909, 10.1002/1097-0142(19930801)72:3<909::AID-CNCR2820720341>3.0.CO;2-O Itami, 1991, Non-Hodgkin’s lymphoma confined to the nasal cavity, Int J Radiat Oncol Biol Phys, 20, 797, 10.1016/0360-3016(91)90026-Z Shikama, 1997, Clinical stage IE primary lymphoma of the nasal cavity, Radiology, 204, 467, 10.1148/radiology.204.2.9240537 Sakata, 1997, Treatment of lethal midline granuloma type nasal T-cell lymphoma, Acta Oncol, 36, 307, 10.3109/02841869709001268 Liang, 1995, Treatment outcome and prognostic factors for primary nasal lymphoma, J Clin Oncol, 13, 666, 10.1200/JCO.1995.13.3.666